Viewing Study NCT06051695


Ignite Creation Date: 2025-12-24 @ 1:41 PM
Ignite Modification Date: 2026-01-01 @ 1:49 PM
Study NCT ID: NCT06051695
Status: RECRUITING
Last Update Posted: 2025-12-12
First Post: 2023-09-18
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
Sponsor: A2 Biotherapeutics Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module